JLE

Hépato-Gastro & Oncologie Digestive

MENU

La cirrhose dysmétabolique : le prochain défi pour les équipes de transplantation hépatique ? Volume 26, numéro 3, Mars 2019

  • [1] Pais R, Barritt AS, Calmus Y, et al. NAFLD and liver transplantation: Current burden and expected challenges. J Hepatol 2016 ; 65 : 1245-1257.
  • [2] Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015 ; 148 : 547-555.
  • [3] Matta J, Zins M, Feral-Pierssens AL, et al. Prévalence du surpoids, de l’obésité et des facteurs de risque cardio-métaboliques dans la cohorte Constances. Bull Epidémiol Hebd 2016 ; (35-36) : 640-6.
  • [4] Nabi O, Lacombe K, Boursier J, et al. (Paris, Anger, Lille, Bordeaux, Villejuif, Strasbourg). Résumé n̊CO-013 Epidémiologie de la stéatose non alcoolique et de la fibrose dans la population générale française : une étude chez 118 664 sujets (NASH-CO). 2018.
  • [5] Younossi Z, Stepanova M, Ong JP, et al. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Clin Gastroenterol Hepatol. 2018 Jun 14. pii : S1542-3565(18)30611-6. doi : 10.1016/j.cgh.2018.05.057.[Epub ahead of print].
  • [6] Condat B, Remy AJ, Jouannaud V, et al. ; Groupe d’étude de l’ANGH. Le recours aux soins pour cirrhose dans les services d’hépato-gastro-entérologie des centres hospitaliers généraux français, 2012. Bull Epidémiol Hebd 2015 ; (24-25) : 450-6.
  • [7] Spengler EK, O’Leary JG, Te HS, et al. Liver Transplantation in the Obese Cirrhotic Patient. Transplantation 2017 ; 101 : 2288-2296.
  • [8] Patel S.S., Nabi E., Guzman L. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation. Liver Transpl. 2018;24:333-342.
  • [9] Harinstein M.E., Flaherty J.D., Ansari A.H. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant. 2008;8:1523-1528.
  • [10] Lentine K.L., Costa S.P., Weir M.R. Cardiac disease evaluation and management among kidney and liver transplantation candidates: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2012;60:434-480.
  • [11] Tsochatzis E, Coilly A, Nadalin S, et al. International Liver Transplantation Consensus Statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation. Transplantation 2019 ; 103 (1) : 45-56.
  • [12] Schlansky B., Naugler W.E., Orloff S.L., Enestvedt C.K. Higher mortality and survival benefit in obese patients awaiting liver transplantation. Transplantation. 2016;100:2648-2655.
  • [13] Patel Y.A., Berg C.L., Moylan C.A. Nonalcoholic Fatty Liver Disease : Key Considerations Before and After Liver Transplantation. Dig Dis Sci. 2016;61:1406-1416.
  • [14] LaMattina J.C., Foley D.P., Fernandez L.A. Complications associated with liver transplantation in the obese recipient. Clin Transplant. 2012;26:910-918.
  • [15] Wang X, Li J, Riaz DR, Shi G, Liu C, Dai Y. Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2014 ; 12 : 394-402.
  • [16] Barritt A.S., Dellon E.S., Kozlowski T., Gerber D.A., Hayashi P.H. The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes. J Clin Gastroenterol. 2011;45:372-378.
  • [17] Nair S., Verma S., Thuluvath P.J. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology. 2002;35:105-109.
  • [18] Saab S., Lalezari D., Pruthi P., Alper T., Tong M.J. The impact of obesity on patient survival in liver transplant recipients: A meta-analysis. Liver Int. 2015;35:164-170.
  • [19] Alvarez J., Mei X., Daily M. Tipping the Scales : Liver Transplant Outcomes of the Super Obese. J Gastrointest Surg. 2016;20:1628-1635.
  • [20] Bhati C., Idowu M.O., Sanyal A.J. Long-term outcomes in patients undergoing liver transplantation for nonalcoholic steatohepatitis-related cirrhosis. Transplantation. 2017;101:1867-1874.
  • [21] Laish I., Braun M., Mor E., Sulkes J., Harif Y., Ben Ari Z. Metabolic syndrome in liver transplant recipients : prevalence, risk factors, and association with cardiovascular events. Liver Transpl. 2011;17:15-22.
  • [22] Bhati C, Idowu MO, Sanyal AJ, et al. Long-term outcomes in patients undergoing liver transplantation for nonalcoholic steatohepatitis-related cirrhosis. Transplantation 2017 ; 101 : 1867-1874.
  • [23] Vanwagner L.B., Bhave M., Te H.S., Feinglass J., Alvarez L., Rinella M.E. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology. 2012;56:1741-1750.
  • [24] Malik SM, deVera ME, Fontes P, Shaikh O, Sasatomi E, Ahmad J. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Transplant 2009 ; 15 : 1843-1851.
  • [25] Malik SM, DeVera ME, Fontes P, Shaikh O, Ahmad J. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 2009 ; 9 : 782-793.
  • [26] Carter D., Dieterich D.T., Chang C. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in liver transplantation. Clin Liver Dis. 2018;22:213-227.
  • [27] VanWagner LB, Bhave M, Te HS, Feinglass J, Alvarez L, Rinella ME. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology 56:1741-1750.
  • [28] Houlihan D.D., Armstrong M.J., Davidov Y. Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: Time to reconsider immunosuppression regimens? Liver Transpl. 2011;17:1292-1298.
  • [29] Bianchi G., Marchesini G., Marzocchi R., Pinna A.D., Zoli M. Metabolic syndrome in liver transplantation : relation to etiology and immunosuppression. Liver Transpl. 2008;14:1648-1654.
  • [30] Thuluvath AJ, Chen P-H, Thuluvath PJ, Kantsevoy S, Savva Y. Poor survival after retransplantation in NASH cirrhosis. Transplantation. 2018.
  • [31] Diwan T.S., Rice T.C., Heimbach J.K., Schauer D.P. Liver Transplantation and bariatric surgery: Timing and outcomes. Liver Transpl. 2018;24:1280-1287.
  • [32] Agopian V.G., Kaldas F.M., Hong J.C. Liver transplantation for nonalcoholic steatohepatitis: The new epidemic. Ann Surg. 2012;256:624-633.
  • [33] Bhagat V., Mindikoglu A.L., Nudo C.G., Schiff E.R., Tzakis A., Regev A. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl. 2009;15:1814-1820.
  • [34] Afzali A., Berry K., Ioannou G.N. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transpl. 2012;18:29-37.
  • [35] Kennedy C., Redden D., Gray S. Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases. HPB (Oxford). 2012;14:625-634.
  • [36] Charlton M.R., Burns J.M., Pedersen R.A., Watt K.D., Heimbach J.K., Dierkhising R.A. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141:1249-1253.
  • [37] Sourianarayanane A., Arikapudi S., McCullough A.J., Humar A. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation. Eur J Gastroenterol Hepatol. 2017;29:481-487.
  • [38] Vallin M., Guillaud O., Boillot O., Hervieu V., Scoazec J.-Y., Dumortier J. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation : natural history based on liver biopsy analysis. Liver Transpl. 2014;20:1064-1071.
  • [39] Yalamanchili K., Saadeh S., Klintmalm G.B., Jennings L.W., Davis G.L. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl. 2010;16:431-439.
  • [40] Dureja P., Mellinger J., Agni R. NAFLD recurrence in liver transplant recipients. Transplantation. 2011;91:684-689.
  • [41] Takata M.C., Campos G.M., Ciovica R. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008;4:159-164.
  • [42] Lin M.Y.C., Tavakol M.M., Sarin A. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis. 2013;9:653-658.
  • [43] Shimizu H., Phuong V., Maia M. Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis. 2013;9:1-6.
  • [44] Heimbach J.K., Watt K.D.S., Poterucha J.J., Ziller N.F., Cecco S.D., Charlton M.R. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant. 2013;13:363-368.
  • [45] Zamora-Valdes D., Watt K.D., Kellogg T.A. Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy. Hepatology. 2018;68:485-495.
  • [46] Lin M.Y.C., Tavakol M.M., Sarin A. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc. 2013;27:81-85.
  • [47] Al-Nowaylati A.-R., Al-Haddad B.J.S., Dorman R.B. Gastric by-pass after liver transplantation. Liver Transpl. 2013;19:1324-1329.
  • [48] Tsamalaidze L., Stauffer J.A., Arasi L.C. Laparoscopic Sleeve Gastrectomy for Morbid Obesity in Patients After Orthotopic Liver Transplant : a Matched Case-Control Study. Obes Surg. 2018;28:444-450.